May Hill Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$514K Buy
1,219
+127
+12% +$50.6K 0.1% 128
2026
Q2
$396K Sell
1,092
-27
-2% -$9.24K 0.08% 154
2026
Q1
$394K Buy
1,119
+196
+21% +$69.9K 0.1% 137
2025
Q4
$302K Buy
923
+17
+2% +$5.39K 0.08% 148
2025
Q3
$256K Sell
906
-23
-2% -$6.67K 0.08% 160
2025
Q2
$259K Sell
929
-388
-29% -$110K 0.09% 155
2025
Q1
$410K Buy
1,317
+62
+5% +$18.3K 0.15% 98
2024
Q4
$327K Buy
+1,255
New +$372K 0.13% 107

Other funds holding AMGN

May Hill Capital's AMGN Position: Q3 2026 in Review

May Hill Capital increased its Amgen (AMGN) stake by 12% in Q3 2026, buying an estimated $50.6K and bringing the position to 1,219 shares worth $514K. The position accounts for 0.1% of the portfolio, ranked #128.

May Hill Capital first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • May Hill Capital held 1,219 shares of Amgen worth $514K as of Q3 2026.
  • May Hill Capital bought 127 Amgen shares in Q3 2026, an estimated $50.6K.
  • Amgen made up 0.1% of May Hill Capital's portfolio in Q3 2026, its #128 holding.
  • May Hill Capital first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.